Effusion Recurrence Index (ERI) Calculator

Effusion Recurrence Index (ERI): rationale, use and limitations The Effusion Recurrence Index (ERI) presented here is a practical, literature-derived point score intended to estimate the risk that a clinically significant pericardial (or pleural) effusion will recur after index drainage or medical management. In multiple series, the presence of malignancy and positive cytology are the most consistent predictors of early recurrence; patients with malignant effusions frequently recur after pericardiocentesis unless managed with indwelling catheters or surgical windows. Additionally, several studies show that initial percutaneous drainage (pericardiocentesis) is associated with higher recurrence compared with surgical drainage or indwelling catheter strategies, and that smaller left ventricular size (relative) and markers of poor nutritional status / inflammation (for example lower Prognostic Nutritional Index) have been associated with higher recurrence in some cohorts.

These factors were combined here into a simple additive score: malignancy and positive cytology are weighted higher, pericardiocentesis receives points, and clinical/echocardiographic features add incremental risk. Clinical use: Use the ERI to aid risk-stratification after an index effusion: a high ERI suggests early multidisciplinary consideration of definitive procedures (surgical window or indwelling catheter) and close oncologic coordination; a low ERI supports conservative follow-up where clinically appropriate. Limitations and recommendation: This ERI is a proposed tool synthesized from published predictors, not a validated clinical decision rule.

The point weights and risk thresholds are pragmatic and must be validated in local cohorts before relying on them for definitive treatment decisions. Always integrate with clinical judgement, tumour stage and patient goals of care. References (selected): Ahmed T, et al.

Predictors of Recurrence and Survival in Cancer Patients with Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022.

Petrofsky JS, et al. Management of Malignant Pericardial Effusion — higher recurrence after pericardiocentesis; review and outcomes. (review article). 2014.

Akao K, et al. Small left ventricular size is a risk factor for recurrent pericardial effusion after drainage. J Clin Med.

2024. Başkurt AA, et al. Prognostic Nutritional Index as a Predictor of Recurrence in Pericardial Effusion.

2025 (cohort analysis). (Additional background: Imazio M, et al. Management of Pericardial Effusion. Eur Heart J.

2013.).